Malignant Mixed Mullerian Tumor Secondary to Tamoxifen for Ca Breast: Shadow of the Past!

Tamoxifen is used in the treatment of hormone-responsive breast cancer because of its antiestrogenic effect. However, it also has an estrogenic effect on the uterus, thereby increasing the risk of endometrial hyperplasia, endometrial polyp, and malignant mixed Mullerian tumor (MMMT). This case descr...

Descripción completa

Detalles Bibliográficos
Autores principales: Bisu, Surendra, Choudhary, Vinu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6332727/
https://www.ncbi.nlm.nih.gov/pubmed/30692818
http://dx.doi.org/10.4103/jmh.JMH_79_18
_version_ 1783387418535133184
author Bisu, Surendra
Choudhary, Vinu
author_facet Bisu, Surendra
Choudhary, Vinu
author_sort Bisu, Surendra
collection PubMed
description Tamoxifen is used in the treatment of hormone-responsive breast cancer because of its antiestrogenic effect. However, it also has an estrogenic effect on the uterus, thereby increasing the risk of endometrial hyperplasia, endometrial polyp, and malignant mixed Mullerian tumor (MMMT). This case describes the pathogenesis and risk of MMMT due to long-term tamoxifen intake in hormone-responsive breast cancer.
format Online
Article
Text
id pubmed-6332727
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-63327272019-01-28 Malignant Mixed Mullerian Tumor Secondary to Tamoxifen for Ca Breast: Shadow of the Past! Bisu, Surendra Choudhary, Vinu J Midlife Health Case Report Tamoxifen is used in the treatment of hormone-responsive breast cancer because of its antiestrogenic effect. However, it also has an estrogenic effect on the uterus, thereby increasing the risk of endometrial hyperplasia, endometrial polyp, and malignant mixed Mullerian tumor (MMMT). This case describes the pathogenesis and risk of MMMT due to long-term tamoxifen intake in hormone-responsive breast cancer. Medknow Publications & Media Pvt Ltd 2018 /pmc/articles/PMC6332727/ /pubmed/30692818 http://dx.doi.org/10.4103/jmh.JMH_79_18 Text en Copyright: © 2018 Journal of Mid-life Health http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Case Report
Bisu, Surendra
Choudhary, Vinu
Malignant Mixed Mullerian Tumor Secondary to Tamoxifen for Ca Breast: Shadow of the Past!
title Malignant Mixed Mullerian Tumor Secondary to Tamoxifen for Ca Breast: Shadow of the Past!
title_full Malignant Mixed Mullerian Tumor Secondary to Tamoxifen for Ca Breast: Shadow of the Past!
title_fullStr Malignant Mixed Mullerian Tumor Secondary to Tamoxifen for Ca Breast: Shadow of the Past!
title_full_unstemmed Malignant Mixed Mullerian Tumor Secondary to Tamoxifen for Ca Breast: Shadow of the Past!
title_short Malignant Mixed Mullerian Tumor Secondary to Tamoxifen for Ca Breast: Shadow of the Past!
title_sort malignant mixed mullerian tumor secondary to tamoxifen for ca breast: shadow of the past!
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6332727/
https://www.ncbi.nlm.nih.gov/pubmed/30692818
http://dx.doi.org/10.4103/jmh.JMH_79_18
work_keys_str_mv AT bisusurendra malignantmixedmulleriantumorsecondarytotamoxifenforcabreastshadowofthepast
AT choudharyvinu malignantmixedmulleriantumorsecondarytotamoxifenforcabreastshadowofthepast

Ejemplares similares